Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Rook

Showing results (71-80 of 110) with videos related to

Pageof 11
Sort By:
Bioorganic & Medicinal Chemistry Letters|May 15, 2018
The discovery of VU0486846: steep SAR from a series of M<sub>1</sub> PAMs based on a novel benzomorpholine coreJeanette L Bertron, Hyekyung P Cho, Pedro M Garcia-Barrantes, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 4, 2013
Biotransformation of a novel positive allosteric modulator of metabotropic glutamate receptor subtype 5 contributes to seizure-like adverse events in rats involving a receptor agonism-dependent mechanismThomas M Bridges, Jerri M Rook, Meredith J Noetzel, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 1, 2017
Co-Activation of Metabotropic Glutamate Receptor 3 and Beta-Adrenergic Receptors Modulates Cyclic-AMP and Long-Term Potentiation, and Disrupts Memory ReconsolidationAdam G Walker, Douglas J Sheffler, Andrew S Lewis, et al.
Bioorganic & Medicinal Chemistry Letters|November 28, 2021
Synthesis and characterization of chiral 6-azaspiro[2.5]octanes as potent and selective antagonists of the M<sub>4</sub> muscarinic acetylcholine receptorAaron M Bender, Trever R Carter, Matthew Spock, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|August 29, 2019
Looking to the Future: Medical Students' Views on Health Care Reform and Professional ResponsibilityJordan M Rook, Tyler N A Winkelman, Jacob A Fox, et al.
Journal of Digital Imaging|January 27, 2022
Qualitative Evaluation of Common Quantitative Metrics for Clinical Acceptance of Automatic Segmentation: a Case Study on Heart Contouring from CT Images by Deep Learning AlgorithmsL B van den Oever, W A van Veldhuizen, L J Cornelissen, et al.
ACS Chemical Neuroscience|February 18, 2014
Identification of specific ligand-receptor interactions that govern binding and cooperativity of diverse modulators to a common metabotropic glutamate receptor 5 allosteric siteKaren J Gregory, Elizabeth D Nguyen, Chrysa Malosh, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 19, 2024
Hispanic/Latino Ethnicity Is an Independent Predictor of Worse Survival for Gastric Cancer in a Multicenter Safety-Net Patient PopulationKyle D Klingbeil, Dustin L Dillon, Erfan Zarrinkhoo, et al.
Molecular Pharmacology|October 25, 2011
Functional impact of allosteric agonist activity of selective positive allosteric modulators of metabotropic glutamate receptor subtype 5 in regulating central nervous system functionMeredith J Noetzel, Jerri M Rook, Paige N Vinson, et al.
Cancer Medicine|January 19, 2024
Tumor therapy by targeting extracellular hydroxyapatite using novel drugs: A paradigm shiftMohammed N Tantawy, J Oliver McIntyre, Fiona Yull, et al.
Pageof 11

Showing results (71-80 of 110) with videos related to

Sort By:
Pageof 11
Bioorganic & Medicinal Chemistry Letters|May 15, 2018
The discovery of VU0486846: steep SAR from a series of M<sub>1</sub> PAMs based on a novel benzomorpholine coreJeanette L Bertron, Hyekyung P Cho, Pedro M Garcia-Barrantes, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 4, 2013
Biotransformation of a novel positive allosteric modulator of metabotropic glutamate receptor subtype 5 contributes to seizure-like adverse events in rats involving a receptor agonism-dependent mechanismThomas M Bridges, Jerri M Rook, Meredith J Noetzel, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|July 1, 2017
Co-Activation of Metabotropic Glutamate Receptor 3 and Beta-Adrenergic Receptors Modulates Cyclic-AMP and Long-Term Potentiation, and Disrupts Memory ReconsolidationAdam G Walker, Douglas J Sheffler, Andrew S Lewis, et al.
Bioorganic & Medicinal Chemistry Letters|November 28, 2021
Synthesis and characterization of chiral 6-azaspiro[2.5]octanes as potent and selective antagonists of the M<sub>4</sub> muscarinic acetylcholine receptorAaron M Bender, Trever R Carter, Matthew Spock, et al.
Academic Medicine : Journal of the Association of American Medical Colleges|August 29, 2019
Looking to the Future: Medical Students' Views on Health Care Reform and Professional ResponsibilityJordan M Rook, Tyler N A Winkelman, Jacob A Fox, et al.
Journal of Digital Imaging|January 27, 2022
Qualitative Evaluation of Common Quantitative Metrics for Clinical Acceptance of Automatic Segmentation: a Case Study on Heart Contouring from CT Images by Deep Learning AlgorithmsL B van den Oever, W A van Veldhuizen, L J Cornelissen, et al.
ACS Chemical Neuroscience|February 18, 2014
Identification of specific ligand-receptor interactions that govern binding and cooperativity of diverse modulators to a common metabotropic glutamate receptor 5 allosteric siteKaren J Gregory, Elizabeth D Nguyen, Chrysa Malosh, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 19, 2024
Hispanic/Latino Ethnicity Is an Independent Predictor of Worse Survival for Gastric Cancer in a Multicenter Safety-Net Patient PopulationKyle D Klingbeil, Dustin L Dillon, Erfan Zarrinkhoo, et al.
Molecular Pharmacology|October 25, 2011
Functional impact of allosteric agonist activity of selective positive allosteric modulators of metabotropic glutamate receptor subtype 5 in regulating central nervous system functionMeredith J Noetzel, Jerri M Rook, Paige N Vinson, et al.
Cancer Medicine|January 19, 2024
Tumor therapy by targeting extracellular hydroxyapatite using novel drugs: A paradigm shiftMohammed N Tantawy, J Oliver McIntyre, Fiona Yull, et al.
Pageof 11